Seoul, South Korea

Hyuntae Kang

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hyuntae Kang: Innovator in Genomic Research

Introduction

Hyuntae Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genomic research, holding a total of 4 patents. His work focuses on innovative methods that enhance our understanding of genetic material and cellular processes.

Latest Patents

Hyuntae Kang's latest patents include a groundbreaking method for amplifying telomeres. This method utilizes an adaptor sequence to amplify the telomere of genomic DNA, along with a composition and kit designed for this purpose. Another notable patent is a composition aimed at reducing senescence in cells or subjects. This composition includes a smurf2 inhibitor and outlines methods for reducing senescence levels, as well as preventing and treating related symptoms or diseases.

Career Highlights

Hyuntae Kang is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of genomic research. His innovative approaches have garnered attention in the scientific community, contributing to advancements in the understanding of cellular aging and genetic stability.

Collaborations

Throughout his career, Hyuntae has collaborated with talented individuals such as Kobong Choi and Joontae Park. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Hyuntae Kang's contributions to genomic research through his patents and collaborations highlight his role as a leading inventor in the field. His innovative methods and compositions are paving the way for future advancements in genetics and cellular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…